` LAB (Standard BioTools Inc) vs S&P 500 Comparison - Alpha Spread

LAB
vs
S&P 500

Over the past 12 months, LAB has underperformed S&P 500, delivering a return of -46% compared to the S&P 500's +13% growth.

Stocks Performance
LAB vs S&P 500

Loading
LAB
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
LAB vs S&P 500

Loading
LAB
S&P 500
Difference
www.alphaspread.com

Performance By Year
LAB vs S&P 500

Loading
LAB
S&P 500
Add Stock

Competitors Performance
Standard BioTools Inc vs Peers

S&P 500
LAB
0KHE
TMO
DHR
207940
Add Stock

Standard BioTools Inc
Glance View

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

LAB Intrinsic Value
0.66 USD
Overvaluation 46%
Intrinsic Value
Price
Back to Top